Primary dysmenorrhea
Conditions
Interventions
Medium-frequency electrical stimulation group:Treatment Timing: Entire menstrual period (from the onset of pain or the first day of menstruation until the end of menstruation)
Treatment Area: The ar
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
Female
Age
13 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. Meeting the diagnostic criteria for primary dysmenorrhea: (1) Exclusion of organic diseases through gynecological examination or ultrasound (such as endometriosis, uterine fibroids, etc.); (2) Cyclical lower abdominal pain during menstruation, which may be accompanied by back pain, nausea, dizziness, etc.; (3) Pain occurring for at least 3 consecutive menstrual cycles. 2. Menstrual regularity: menstrual cycle of 21–35 days, menstruation lasting 3–7 days. 3. Age range: generally women aged 13–40 years. 4. Pain severity meeting study requirements: using the Visual Analog Scale (VAS) >= 4 points (moderate to severe dysmenorrhea). 5. No use of medications or treatments affecting the results: no TENS, electroacupuncture, hormone therapy, oral contraceptives, or other long-term analgesic treatments in the past 3 months. 6. Voluntarily participating in the study and signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Secondary dysmenorrhea or organic diseases: such as endometriosis, adenomyosis, acute or chronic reproductive tract inflammation, cervical stenosis, uterine fibroids, etc. 2. Use of drugs or treatments that may affect dysmenorrhea: those who have used hormones, intrauterine devices, oral contraceptives, or analgesic treatment in the past 3 months. 3. Individuals with a cardiac pacemaker or other electronic implants (TENS contraindicated). 4. Combined severe systemic diseases: such as cardiovascular, nervous system, liver and kidney dysfunction, mental disorders, etc. 5. Pregnant or breastfeeding women. 6. Individuals with skin lesions or damage/infection at the electrode application site. 7. Those unable to cooperate with treatment or with incomplete follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale for Abdominal Pain During Menstruation;Duration of menstrual pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the nature of pain: pain descriptors (stabbing/dull/cramping, etc.);Accompanying symptoms: lower back pain, nausea, dizziness, fatigue, etc. (present/absent);Self-Rating Anxiety;Self-Rating Depression ;Onset time: Record the time point when the pain begins to ease;Rescue medication situation: whether used, number of uses, total dose;Daily usage compliance: actual number of days used, daily usage duration;Willingness to recommend: Whether willing to recommend to others; | — |
Countries
China
Contacts
Public ContactWei Zhaolian
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed